Cargando…

Elevated 4R‐tau in astrocytes from asymptomatic carriers of the MAPT 10+16 intronic mutation

The microtubule‐associated protein tau gene (MAPT) 10+16 intronic mutation causes frontotemporal lobar degeneration (FTLD) by increasing expression of four‐repeat (4R)‐tau isoforms. We investigated the potential role for astrocytes in the pathogenesis of FTLD by studying the expression of 4R‐tau. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Setó‐Salvia, Núria, Esteras, Noemi, de Silva, Rohan, de Pablo‐Fernandez, Eduardo, Arber, Charles, Toomey, Christina E., Polke, James M., Morris, Huw R., Rohrer, Jonathan D., Abramov, Andrey Y., Patani, Rickie, Wray, Selina, Warner, Thomas T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831975/
https://www.ncbi.nlm.nih.gov/pubmed/34951131
http://dx.doi.org/10.1111/jcmm.17136
_version_ 1784648625286021120
author Setó‐Salvia, Núria
Esteras, Noemi
de Silva, Rohan
de Pablo‐Fernandez, Eduardo
Arber, Charles
Toomey, Christina E.
Polke, James M.
Morris, Huw R.
Rohrer, Jonathan D.
Abramov, Andrey Y.
Patani, Rickie
Wray, Selina
Warner, Thomas T.
author_facet Setó‐Salvia, Núria
Esteras, Noemi
de Silva, Rohan
de Pablo‐Fernandez, Eduardo
Arber, Charles
Toomey, Christina E.
Polke, James M.
Morris, Huw R.
Rohrer, Jonathan D.
Abramov, Andrey Y.
Patani, Rickie
Wray, Selina
Warner, Thomas T.
author_sort Setó‐Salvia, Núria
collection PubMed
description The microtubule‐associated protein tau gene (MAPT) 10+16 intronic mutation causes frontotemporal lobar degeneration (FTLD) by increasing expression of four‐repeat (4R)‐tau isoforms. We investigated the potential role for astrocytes in the pathogenesis of FTLD by studying the expression of 4R‐tau. We derived astrocytes and neurons from induced pluripotent stem cells from two asymptomatic 10+16 carriers which, compared to controls, showed persistently increased 4R:3R‐tau transcript and protein ratios in both cell types. However, beyond 300 days culture, 10+16 neurons showed less marked increase of this 4R:3R‐tau transcript ratio compared to astrocytes. Interestingly, throughout maturation, both 10+16 carriers consistently displayed different 4R:3R‐tau transcript and protein ratios. These elevated levels of 4R‐tau in astrocytes implicate glial cells in the pathogenic process and also suggests a cell‐type‐specific regulation and may inform and help on treatment of pre‐clinical tauopathies.
format Online
Article
Text
id pubmed-8831975
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-88319752022-02-14 Elevated 4R‐tau in astrocytes from asymptomatic carriers of the MAPT 10+16 intronic mutation Setó‐Salvia, Núria Esteras, Noemi de Silva, Rohan de Pablo‐Fernandez, Eduardo Arber, Charles Toomey, Christina E. Polke, James M. Morris, Huw R. Rohrer, Jonathan D. Abramov, Andrey Y. Patani, Rickie Wray, Selina Warner, Thomas T. J Cell Mol Med Short Communications The microtubule‐associated protein tau gene (MAPT) 10+16 intronic mutation causes frontotemporal lobar degeneration (FTLD) by increasing expression of four‐repeat (4R)‐tau isoforms. We investigated the potential role for astrocytes in the pathogenesis of FTLD by studying the expression of 4R‐tau. We derived astrocytes and neurons from induced pluripotent stem cells from two asymptomatic 10+16 carriers which, compared to controls, showed persistently increased 4R:3R‐tau transcript and protein ratios in both cell types. However, beyond 300 days culture, 10+16 neurons showed less marked increase of this 4R:3R‐tau transcript ratio compared to astrocytes. Interestingly, throughout maturation, both 10+16 carriers consistently displayed different 4R:3R‐tau transcript and protein ratios. These elevated levels of 4R‐tau in astrocytes implicate glial cells in the pathogenic process and also suggests a cell‐type‐specific regulation and may inform and help on treatment of pre‐clinical tauopathies. John Wiley and Sons Inc. 2021-12-24 2022-02 /pmc/articles/PMC8831975/ /pubmed/34951131 http://dx.doi.org/10.1111/jcmm.17136 Text en © 2021 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Short Communications
Setó‐Salvia, Núria
Esteras, Noemi
de Silva, Rohan
de Pablo‐Fernandez, Eduardo
Arber, Charles
Toomey, Christina E.
Polke, James M.
Morris, Huw R.
Rohrer, Jonathan D.
Abramov, Andrey Y.
Patani, Rickie
Wray, Selina
Warner, Thomas T.
Elevated 4R‐tau in astrocytes from asymptomatic carriers of the MAPT 10+16 intronic mutation
title Elevated 4R‐tau in astrocytes from asymptomatic carriers of the MAPT 10+16 intronic mutation
title_full Elevated 4R‐tau in astrocytes from asymptomatic carriers of the MAPT 10+16 intronic mutation
title_fullStr Elevated 4R‐tau in astrocytes from asymptomatic carriers of the MAPT 10+16 intronic mutation
title_full_unstemmed Elevated 4R‐tau in astrocytes from asymptomatic carriers of the MAPT 10+16 intronic mutation
title_short Elevated 4R‐tau in astrocytes from asymptomatic carriers of the MAPT 10+16 intronic mutation
title_sort elevated 4r‐tau in astrocytes from asymptomatic carriers of the mapt 10+16 intronic mutation
topic Short Communications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831975/
https://www.ncbi.nlm.nih.gov/pubmed/34951131
http://dx.doi.org/10.1111/jcmm.17136
work_keys_str_mv AT setosalvianuria elevated4rtauinastrocytesfromasymptomaticcarriersofthemapt1016intronicmutation
AT esterasnoemi elevated4rtauinastrocytesfromasymptomaticcarriersofthemapt1016intronicmutation
AT desilvarohan elevated4rtauinastrocytesfromasymptomaticcarriersofthemapt1016intronicmutation
AT depablofernandezeduardo elevated4rtauinastrocytesfromasymptomaticcarriersofthemapt1016intronicmutation
AT arbercharles elevated4rtauinastrocytesfromasymptomaticcarriersofthemapt1016intronicmutation
AT toomeychristinae elevated4rtauinastrocytesfromasymptomaticcarriersofthemapt1016intronicmutation
AT polkejamesm elevated4rtauinastrocytesfromasymptomaticcarriersofthemapt1016intronicmutation
AT morrishuwr elevated4rtauinastrocytesfromasymptomaticcarriersofthemapt1016intronicmutation
AT rohrerjonathand elevated4rtauinastrocytesfromasymptomaticcarriersofthemapt1016intronicmutation
AT abramovandreyy elevated4rtauinastrocytesfromasymptomaticcarriersofthemapt1016intronicmutation
AT patanirickie elevated4rtauinastrocytesfromasymptomaticcarriersofthemapt1016intronicmutation
AT wrayselina elevated4rtauinastrocytesfromasymptomaticcarriersofthemapt1016intronicmutation
AT warnerthomast elevated4rtauinastrocytesfromasymptomaticcarriersofthemapt1016intronicmutation